Presentation TCT 2017

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Presenter: Grzegorz Smolka, MD

October 31, 2017

REGISTER for free or LOG IN to view this content

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Structural Heart

Presentation

TCT 2017

Left Atrial Appendage

Up Next

Presentation TCT 2017

TCT 102: Five-Year Outcomes of Left Atrial Appendage Closure: Final Results of the Continued Access to PROTECT AF (CAP) Registry

Presenter: David R. Holmes Jr.

October 31, 2017

More slides +

Presentation TCT 2017

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

Presenter: Christopher Capps, MD

October 31, 2017

Presentation TCT 2017

TCT 104: Initial Pre-clinical and Clinical Use of Mechanical Intracardiac Echocardiography System With 3D Viewing, Color Doppler, and Side-Viewing Capabilities

Presenter: Brian Courtney, MD

October 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.